Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Interview: June Raine and the rise of pharmacovigilance and risk management

This article was originally published in SRA

Executive Summary

Barely three years old, the Pharmacovigilance Risk Assessment Committee is the European Medicine Agency's new kid on the block. The PRAC, according to its chair Dr June Raine, is a "clear voice for public health" that will only get louder as companies and regulators increasingly focus on providing earlier access to medicines and demand for real life data grows. Dr Raine talks to Scrip Regulatory Affairs about the PRAC's role in risk management, adaptive pathways, data gathering and the voice of the patient.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst